The surgical outcomes of colon cancer vary with its anatomical location. Neoadjuvant chemotherapy can aid in improving the postsurgical outcomes of both right and left colon cancer, decreasing the ...
A short burst of immunotherapy before surgery is delivering surprisingly powerful results for a specific type of colorectal ...
We conducted phase II nonrandomized open-label clinical trial (ClinicalTrials.gov identifier: NCT06428487) in patients with locally advanced colorectal cancer (CRC) and dMMR/MSI. Prolgolimab (1 mg/kg) ...
A 26-year-old is now "cancer-free" after receiving a new treatment for colorectal cancer. "I was declared cancer free in July of 2025, and I've taken three trips since then," Mrinali Dhembla, 26, told ...
Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, ...
Molecular/genomic profiling is expanding precision selection of systemic therapy and may enable immunotherapy-driven organ ...
A phase 3, randomized, double-blind, placebo-controlled study of lecithinized superoxide dismutase (PC-SOD) for the prevention of chemotherapy-induced peripheral neuropathy in patients with colorectal ...
TNT achieved a 93.7% complete response rate and 87.5% organ preservation in stage I rectal cancer patients. TNT may offer an organ-preserving alternative to surgery, especially for low-lying tumors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results